Search Within
Document Type
215-171-9
Applied Filters:
Keyword:'215-171-9'
Showing 1-30 of 53 results for "215-171-9" within Technical Documents
Product Information Sheet - S4500
synthesis by Fusobacterium
nucleatum grown in continuous culture. FEMS
Microbiol. Lett., 215(2), 203-208 (2002).
9. Blauwkamp, T. A., and Ninfa, A. J., Nac-mediated
repression of the serA promoter of
Product Information Sheet - P7130
Nephrol.,
23(2), 161-171 (2003).
4. Mattoo, T. K., and Kovacevic, L., Effect of grape
seed extract on puromycin-aminonucleoside-
induced nephrosis in rats. Pediatr. Nephrol.,
18(9), 872-877 (2003).
Product Information Sheet - E1383
7. Sieber, S.M. et al., Teratology 18, 31, (1978).
8. Stahelin, H., Europ. J. Cancer, 9, 215, (1973).
9. Clark, P.I. and Slevin, M.L., Clinical Pharmacokinetics 12, 223, (1987) (review).
10. Martindale
Data Sheet - A0781
inhibition of the DNA
polymerase of Methanococcus vannielii by
aphidicolin. Eur. J. Biochem., 165, 171-175
(1987).
15. Marheineke, K., and Hyrien, O., Aphidicolin
triggers a block to replication origin
Product Information Sheet - C6880
), Unit
1.4, p. 1-9 (John Wiley & Sons, Inc., New
York,1999).
5. Kuehl, F.A., Jr. et al., J. Am. Chem. Soc., 77, 2344
(1955).
6. Sirvio, J., et al., Neurosci. Lett., 146, 215 (1992).
7. Ohno, M
Product Information Sheet - C7670
), Unit
1.4, p. 1-9 (John Wiley & Sons, Inc., New
York,1999).
5. Kuehl, F.A., Jr. et al., J. Am. Chem. Soc., 77, 2344
(1955).
6. Sirvio, J., et al., Neurosci. Lett., 146, 215 (1992).
7. Ohno, M
Product Information Sheet - C3909
), Unit
1.4, p. 1-9 (John Wiley & Sons, Inc., New
York,1999).
5. Kuehl, F.A., Jr. et al., J. Am. Chem. Soc., 77, 2344
(1955).
6. Sirvio, J., et al., Neurosci. Lett., 146, 215 (1992).
7. Ohno, M
Data Sheet - 30020
Eds.), Unit 1.4, p. 1-9 (John Wiley & Sons,
Inc., New York,1999).
5. Kuehl, F.A., Jr. et al., J. Am. Chem. Soc., 77, 2344 (1955).
6. Sirvio, J., et al., Neurosci. Lett., 146, 215 (1992).
7. Ohno, M
Quality Control Range Sheet- A6602-106 and A6602-206
mL Control 2 258 – 537 pg/mL
MCP-3 Control 1 280 – 582 pg/mL VEGF-A Control 1 82 – 171 pg/mL
Control 2
Quality Control Range Sheet- A6602-106 and A6602-206
mL Control 2 258 – 537 pg/mL
MCP-3 Control 1 280 – 582 pg/mL VEGF-A Control 1 82 – 171 pg/mL
Control 2
XP725 Antibody Number-Lot Number 071M4826
23 24 45 46 47 48 69 70 71 72 93 94 95 96
2.1 97 98 99 100 121 122 123 124 145 146 147 148 169 170 171 172
2.2 101 102 103 104 125 126 127 128 149 150
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
114 2 198 4 247 5
IPI00479708 IGHM protein 131 3 87 3
IPI00419424 IGKV1-5 protein 154 2 183 2 171 3 147 2
IPI00719373 IGLC1 protein 202 3
IPI00719452 IGLC1 protein 99 2 81 1
Specific Detection of Full-length Glucagon from Blood Samples Using a Chemiluminescent ELISA Kit
A
1 26.30 73
2 46.40 80
3 27.30 267
4 58.10 140
5 53.30 156
6 53.50 101
7 7.50 249
8 46.40 215
9 13.00 74
10 8.25 51
11 22.00 73
12 25.10
Protocol: Human PYY (Total) ELISA Kit - 96-Well Plate
Basal) 115 -- 130 --
40 145 75% 171 103%
100 197 82% 232 102%
500 525 82% 658 106%
C
0 (Basal) 144 -- 172
Protocol- EZHPYTT66K
B
0 (Basal) 115 - 130 -
40 145 75% 171 103%
100 197 82% 232 102%
500 525 82% 658 106%
C
0 (Basal) 144 - 172 -
40 172 70% 214 105%
Protocol- EZHPYYT66K
B
0 (Basal) 115 - 130 -
40 145 75% 171 103%
100 197 82% 232 102%
500 525 82% 658 106%
C
0 (Basal) 144 - 172 -
40 172 70% 214 105%
Product Information - CSAA1
3) Clone:CYT3 G6541 Signal Transduction M y n/d y
170 CRK-L C0978 Signal Transduction P y y n/d
171 CAM Kinase IIα C6974 Signal Transduction P y y y
172 CAM Kinase IV (Ay-18) C2851 Signal Transduction
Programming data for Spectrophotometer and Spectroquant Test Kits
Hardness 1.00961 CT
5 215 mg/l Ca 16 mm
A) 565 DW
13 538 mg/l CaCO3 16 mm
7 301 mg/l CaO 16 mm
0.7 30.1 °d 16 mm
0.9 37.6 °e
Mobius® and UltraMobius
Schroeter, A. and Borriss, R. (1988) Mol. Gen. Genet. 215,
181-183.
5. Riethdorf, S., Schroeter, A. and Hecker, M. (1989) Genet. Res. 54, 167-171.
6. Hofmann, K.H., Neubauer, P., Riethdorf, S. and
Mobius® and UltraMobius 1000 Plasmid Kits
Schroeter, A. and Borriss, R. (1988) Mol. Gen. Genet. 215,
181–183.
6. Riethdorf, S., Schroeter, A. and Hecker, M. (1989) Genet. Res. 54, 167–171.
7. Hofmann, K.H., Neubauer, P., Riethdorf, S.
User Guide Equinox SOP Software 2.1 for Windows XP
..................................................................
ii — Inhalt
169
169
170
171
171
172
173
174
174
174
175
175
177
177
178
179
179
179
180
181
183
185
Kapitel 1
ExPlore with Confidence: Prestige Antibodies Breast Cancer Research
coilin from prote-
asomal degradation in cell cycle. Sci Rep 2015 Jun 12; 5:10543. Epub 2015 Jun 12.
171. García E et al. WIP and WICH/WIRE co-ordinately control invadopodium formation
and maturation in
Inhibitor Sourcebook 3rd Edition
........................... 215
239764 ........................................................... 215
239765 ........................................................... 215
239783 .....................
Perfection in every dimension 2014. Inorganic reagents Catalogue
188052 171
Water standard 5 mg / ml (1 ml contains 5 mg H2O) Apura® 109259 171
Water standard oil standard for oil samples for coulometric Karl Fischer titration (15 – 30 ppm) Apura® 188055 171
Water
3D BIOPRINTING: Printing a Brighter Future
.; Khang, G.;
Lee, S. J.; Yoo, J. J.; Park, C. H. Nat. Commun. 2018, 9, 1620.
(129) Kabirian, F.; Mozafari, M. Methods 2020, 171, 108–118.
(130) Kim, B. S.; Das, S.; Jang, J.; Cho, D.-W. Chem. Rev.
3D BIOPRINTING: Printing a Brighter Future
.; Khang, G.;
Lee, S. J.; Yoo, J. J.; Park, C. H. Nat. Commun. 2018, 9, 1620.
(129) Kabirian, F.; Mozafari, M. Methods 2020, 171, 108–118.
(130) Kim, B. S.; Das, S.; Jang, J.; Cho, D.-W. Chem. Rev.
XP725 Antibody List Lot 089K4791
diphosphorylated p38) M8177 1432 MAPK14 M NP_001306.1 y y y
189 Csk C7863 1445 CSK P NP_001120662.1 y n/d y
171 Casein Kinase 2α C5367 1457 CSNK2A1 M NP_001886.1 ,NP_808227.1, NP_808228.1 y y y
111 Casein Kinase
XP725 Antibody List Lot 129K4831
diphosphorylated p38) M8177 1432 MAPK14 M NP_001306.1 y y y
189 Csk C7863 1445 CSK P NP_001120662.1 y n/d y
171 Casein Kinase 2α C5367 1457 CSNK2A1 M NP_001886.1 ,NP_808227.1, NP_808228.1 y y y
111 Casein Kinase
XP725 Antibody List Lot 129K4830
diphosphorylated p38) M8177 1432 MAPK14 M NP_001306.1 y y y
189 Csk C7863 1445 CSK P NP_001120662.1 y n/d y
171 Casein Kinase 2α C5367 1457 CSNK2A1 M NP_001886.1 ,NP_808227.1, NP_808228.1 y y y
111 Casein Kinase
A list of advantages for the global market
100805 Titanium(IV) oxide, suitable for use as excipient
EMPROVE® exp Ph Eur, BP, USP, JP, E 171
EXP • • • • •
137004 Titriplex® III (Ethylenedinitrotetraacetic acid disodium salt
dihydrate
Page 1 of 2